[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Acute exacerbations of COPD (AECOPD) are important events in the natural history of this condition because they negatively impact health status, rate of hospitalization, disease progression, and mortality. Vi...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Domenico Lorenzo Urso
Format:	Artykuł
Język:	English
Wydane:	SEEd 2017-07-01
Seria:	Clinical Management Issues
Hasła przedmiotowe:	COPD Exacerbations Bronchitis Bronchodilators
Dostęp online:	https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1308

Podobne zapisy

Exacerbations of COPD
od: Pavord ID, i wsp.
Wydane: (2016-02-01)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
od: Junghyun Kim, i wsp.
Wydane: (2017-05-01)

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
od: Hideyasu Yamada, i wsp.
Wydane: (2022-09-01)

Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
od: Stephen A. Mein, MD, i wsp.
Wydane: (2025-03-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
od: V. V. Arkhipov
Wydane: (2018-10-01)

COPD phenotypes: differences in survival
od: Hernández Vázquez J, i wsp.
Wydane: (2018-07-01)

Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations
od: Cheng YS, i wsp.
Wydane: (2017-07-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
od: Miravitlles M, i wsp.
Wydane: (2022-07-01)

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
od: Anja Jochmann, i wsp.
Wydane: (2012-03-01)

Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort
od: Kim EK, i wsp.
Wydane: (2021-11-01)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
od: Chuchalin Alexander, i wsp.
Wydane: (2013-01-01)

Managment acute exacerbation of chronic obstructive pulmonary disease
od: Pavlović Tanja, i wsp.
Wydane: (2018-01-01)

Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial
od: Beeh KM, i wsp.
Wydane: (2016-11-01)

Approach to: Chronic obstructive pulmonary disease (COPD)
od: Alexander Ni
Wydane: (2020-10-01)

The prognostic value of hypophosphatemia in acute exacerbation of chronic obstructive pulmonary disease (COPD)
od: Ibrahim El-Sayed, i wsp.
Wydane: (2017-08-01)

Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study
od: Juan Marco Figueira‐Gonçalves, i wsp.
Wydane: (2022-07-01)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
od: Sean Duffy, i wsp.
Wydane: (2017-06-01)

Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease
od: van Geffen WH, i wsp.
Wydane: (2018-04-01)

Do 'guidelines' really guide us?
od: Milićević-Nešić Ivana J.
Wydane: (2017-01-01)

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
od: Ian Naya, i wsp.
Wydane: (2019-03-01)

Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease
od: Bouhuis D, i wsp.
Wydane: (2023-04-01)

Acute exacerbations of COPD
od: W MaxNee
Wydane: (2003-05-01)

The value of the medicine fenoterol + ipratropium bromide in the treatment of exacerbations of bronchial asthma and chronic obstructive pulmonary disease
od: О. A. Tsvetkova, i wsp.
Wydane: (2020-11-01)

Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis
od: Ruan Spies, i wsp.
Wydane: (2021-07-01)

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease
od: Cristina Estirado, i wsp.
Wydane: (2018-06-01)

Serum Troponin-I as a prognostic marker in acute exacerbated chronic obstructive pulmonary disease patients
od: Abdel Rahim I. Youssef, i wsp.
Wydane: (2013-10-01)

Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America
od: Naranjo L, i wsp.
Wydane: (2020-08-01)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
od: Halpin DMG, i wsp.
Wydane: (2017-10-01)

The adjusted impact of different severities of acute exacerbations and medications on the risk of developing dementia in COPD patients
od: Kuo-Hua Chia, i wsp.
Wydane: (2023-03-01)

The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
od: Wise RA, i wsp.
Wydane: (2021-03-01)

AN OBSERVATIONAL SYUDY ON THE ROLE OF DECAF SCORE IN PREDICTING PROGNOSIS IN PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
od: Rituporna Chanda, i wsp.
Wydane: (2023-06-01)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
od: Ferguson GT, i wsp.
Wydane: (2020-11-01)

Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study
od: Dorina Esendağlı, i wsp.
Wydane: (2024-11-01)

Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort
od: Pascal Urwyler, i wsp.
Wydane: (2019-02-01)

Value of copeptin and C-reactive protein in acute exacerbation of chronic obstructive pulmonary disease
od: Tamer Said Morsi, i wsp.
Wydane: (2014-10-01)

THE CASE OF PULMONARY EMBOLISM IN A PATIENT WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
od: M. A. Karnaushkina, i wsp.
Wydane: (2016-10-01)

Management of chronic obstructive pulmonary disease exacerbations in Internal Medicine
od: Gelorma Belmonte, i wsp.
Wydane: (2013-03-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
od: Kwok WC, i wsp.
Wydane: (2023-06-01)

Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: a systematic review
od: Niamh Kelly, i wsp.
Wydane: (2021-09-01)

Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial
od: Brigitte Engel, i wsp.
Wydane: (2017-05-01)